Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Standardization of a CT Protocol for Imaging Patients with Suspected COVID-19-A RACOON Project.
Steuwe A, Kamp B, Afat S, Akinina A, Aludin S, Bas EG, Berger J, Bohrer E, Brose A, Büttner SM, Ehrengut C, Gerwing M, Grosu S, Gussew A, Güttler F, Heinrich A, Jiraskova P, Kloth C, Kottlors J, Kuennemann MD, Liska C, Lubina N, Manzke M, Meinel FG, Meyer HJ, Mittermeier A, Persigehl T, Schmill LP, Steinhardt M, The Racoon Study Group, Antoch G, Valentin B. Steuwe A, et al. Among authors: antoch g. Bioengineering (Basel). 2024 Feb 22;11(3):207. doi: 10.3390/bioengineering11030207. Bioengineering (Basel). 2024. PMID: 38534481 Free PMC article.
High-risk breast cancer surveillance with MRI: 10-year experience from the German consortium for hereditary breast and ovarian cancer.
Bick U, Engel C, Krug B, Heindel W, Fallenberg EM, Rhiem K, Maintz D, Golatta M, Speiser D, Rjosk-Dendorfer D, Lämmer-Skarke I, Dietzel F, Schäfer KWF, Leinert E, Weigel S, Sauer S, Pertschy S, Hofmockel T, Hagert-Winkler A, Kast K, Quante A, Meindl A, Kiechle M, Loeffler M, Schmutzler RK; German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC). Bick U, et al. Breast Cancer Res Treat. 2019 May;175(1):217-228. doi: 10.1007/s10549-019-05152-9. Epub 2019 Feb 6. Breast Cancer Res Treat. 2019. PMID: 30725383
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation.
Umutlu L, Beyer T, Grueneisen JS, Rischpler C, Quick HH, Veit-Haibach P, Eiber M, Purz S, Antoch G, Gatidis S, Nikolaou K, Schaefer JF, Rausch I, Herrmann K; Vorstand der Interdisziplinären AG für Hybride Bildgebung in alphabetischer Reihenfolge:; Vorstand der Deutschen Röntgengesellschaft (DRG) und der Deutschen Gesellschaft für Nuklearmedizin (DGN) in alphabetischer Reihenfolge:. Umutlu L, et al. Among authors: antoch g. Nuklearmedizin. 2019 Mar;58(2):68-76. doi: 10.1055/a-0830-4453. Epub 2019 Feb 28. Nuklearmedizin. 2019. PMID: 30818412 Free article. English.
Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial.
Krilaviciute A, Kaaks R, Seibold P, de Vrieze M, Lakes J, Radtke JP, Kuczyk M, Harke NN, Debus J, Fink CA, Herkommer K, Gschwend JE, Meissner VH, Benner A, Kristiansen G, Hadaschik B, Arsov C, Schimmöller L, Antoch G, Giesel FL, Makowski M, Wacker F, Schlemmer HP, Becker N, Albers P. Krilaviciute A, et al. Among authors: antoch g. Eur Urol. 2024 May 15:S0302-2838(24)02358-3. doi: 10.1016/j.eururo.2024.04.030. Online ahead of print. Eur Urol. 2024. PMID: 38749854 Free article.
Aggressive Lymphoma after CD19 CAR T-Cell Therapy.
Kobbe G, Brüggemann M, Baermann BN, Wiegand L, Trautmann H, Yousefian S, Libertini S, Menssen HD, Maier HJ, Ulrich P, Gao J, Bruch PM, Liebers N, Radujkovic A, Seifert M, Schniederjohann C, Paramasivam N, Fitzgerald D, Seidel M, Esposito I, Germing U, Cadeddu RP, Nachtkamp K, Jäger P, Ulrych T, Fischer JC, Rox JM, Giesel F, Koch R, Antoch G, Distler JHW, Meuth SG, Jacobsen M, Hübschmann D, Lu J, Iaccarino I, Haas S, Damm F, Dietrich S. Kobbe G, et al. Among authors: antoch g. N Engl J Med. 2024 Oct 3;391(13):1217-1226. doi: 10.1056/NEJMoa2402730. N Engl J Med. 2024. PMID: 39589371
A challenging discrimination of an intensely [18F]PSMA-1007-avid solitary lesion at the skull base in a patient with biochemical recurrence of prostate cancer.
Novruzov E, Niegisch G, Pauck D, Schmitt D, Kuhlmann J, Beseoglu K, Antoch G, Schimmöller L, Giesel FL, Mamlins E. Novruzov E, et al. Among authors: antoch g. BJR Case Rep. 2024 Nov 1;10(6):uaae041. doi: 10.1093/bjrcr/uaae041. eCollection 2024 Nov. BJR Case Rep. 2024. PMID: 39553424 Free PMC article.
533 results